Search Results

Efficacy of Combined Bevacizumab and Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Type 1 Receptor Blockers in Metastatic Colorectal Cancer Patients.

• Authors : Güren, Ali Kaan ; Majidova, Nargiz¹; Çakır, İclal²

• Source: Middle East Journal of Cancer. Apr2025, Vol. 16 Issue 2, p162-169. 8p.

Record details

Losartan as a mechanotherapeutic adjuvant: Remodeling the breast tumor microenvironment to improve treatment efficacy.

• Authors : Dwairy M; Department of Civil Engineering, Yarmouk University, Irbid, Jordan.; Department of Biomedical Systems and Informatics Engineering, Yarmouk University, Irbid, Jordan.

Subjects: Losartan*/Losartan*/Losartan*/pharmacology ; Losartan*/Losartan*/Losartan*/pharmacokinetics ; Losartan*/Losartan*/Losartan*/therapeutic use

• Source: PloS one [PLoS One] 2025 Jul 11; Vol. 20 (7), pp. e0328196. Date of Electronic Publication: 2025 Jul 11 (Print Publication: 2025).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

Angiotensin converting enzyme inhibitors versus angiotensin II type 1 receptor blockers in patients with acute myocardial infarction and prediabetes after successful implantation of newer-generation drug-eluting stents

• Authors : Seunghwan Kim; Donghoon Choi; Yong Hoon Kim

Subjects: Myocardial Infarction; Angiotensin-Converting Enzyme Inhibitors; Drug-Eluting Stents

• Source: Cardiol J

Record details

Sacubitril/Valsartan attenuates progression of diabetic cardiomyopathy through immunomodulation properties: an opportunity to prevent progressive disease.

• Authors : Karuna N; Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, UK.; Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand.

Subjects: Biphenyl Compounds*/Biphenyl Compounds*/Biphenyl Compounds*/pharmacology ; Aminobutyrates*/Aminobutyrates*/Aminobutyrates*/pharmacology ; Valsartan*/Valsartan*/Valsartan*/pharmacology

• Source: Cardiovascular diabetology [Cardiovasc Diabetol] 2025 May 14; Vol. 24 (1), pp. 206. Date of Electronic Publication: 2025 May 14.Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840

Record details

Comparative Efficacy of Angiotensin II Type 1 Receptor Blockers Against Ventilator‐Induced Diaphragm Dysfunction in Rats

• Authors : Aaron B. Morton; Kurt J. Sollanek; Hayden W. Hyatt

Subjects: Ventilators, Mechanical; Research; Diaphragm

• Source: Clin Transl SciClinical and Translational Science, Vol 14, Iss 2, Pp 481-486 (2021)

Record details

A Study of Morphological Changes in Renal Afferent Arterioles Induced by Angiotensin II Type 1 Receptor Blockers in Hypertensive Patients

• Authors : Kazushige Nakanishi; Yosuke Sasaki; Fumito Yamabe

Subjects: Male; hypertension; Dermatology

• Source: Kidney & Blood Pressure Research, Pp 157-171 (2020)

Record details

The protective effect of angiotensin II type I receptor blocker (valsartan) on behavioral impairment, NLRP3, BDNF, and oxidative stress in the brain tissue of ovariectomized female rats.

• Authors : Erdem S; Ahmet Erdoğan Vocational School of Health Services, Pathology Program, Zonguldak Bülent Ecevit University, Zonguldak, Turkey.; Özaçmak HS

Subjects: Angiotensin II Type 1 Receptor Blockers*/Angiotensin II Type 1 Receptor Blockers*/Angiotensin II Type 1 Receptor Blockers*/pharmacology ; Anxiety*/Anxiety*/Anxiety*/drug therapy ; Anxiety*/Anxiety*/Anxiety*/metabolism

• Source: Physiological reports [Physiol Rep] 2024 Oct; Vol. 12 (20), pp. e70003.Publisher: published by Wiley Periodicals, Inc. on behalf of the American Physiological Society and The Physiological Society Country of Publication: United States NLM

Record details

Severe acute respiratory syndrome coronavirus 2 infection, angiotensin-converting enzyme 2 and treatment with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers

• Authors : Federico Giulietti; Piero Giordano; Riccardo Sarzani

Subjects: Renin-Angiotensin System; 0301 basic medicine; 03 medical and health sciences

• Source: European Journal of Preventive Cardiology. 28:e10-e13

Record details

Age-Related Effects of AT1 Receptor Antagonist Losartan on Cognitive Decline in Spontaneously Hypertensive Rats.

• Authors : Tchekalarova J; Department of Behavioral Neurobiology, Institute of Neurobiology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.; Department of Organic Chemistry, University of Chemical Technology and Metallurgy, 1756 Sofia, Bulgaria.

Subjects: Losartan*/Losartan*/Losartan*/pharmacology ; Losartan*/Losartan*/Losartan*/therapeutic use ; Rats, Inbred SHR*

• Source: International journal of molecular sciences [Int J Mol Sci] 2024 Jul 04; Vol. 25 (13). Date of Electronic Publication: 2024 Jul 04.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

Solid dispersion systems for enhanced dissolution of poorly water-soluble candesartan cilexetil: In vitro evaluation and simulated pharmacokinetics studies.

• Authors : Ali ISM; Pharmaceutics Department, College of Pharmacy, University of Basrah, Basrah, Iraq.; Sajad UA

Subjects: Benzimidazoles*/Benzimidazoles*/Benzimidazoles*/pharmacokinetics ; Biphenyl Compounds*/Biphenyl Compounds*/Biphenyl Compounds*/chemistry ; Biphenyl Compounds*/Biphenyl Compounds*/Biphenyl Compounds*/pharmacokinetics

• Source: PloS one [PLoS One] 2024 Jun 06; Vol. 19 (6), pp. e0303900. Date of Electronic Publication: 2024 Jun 06 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details